论文部分内容阅读
目的:探究蓝光治疗照射对新生儿ABO溶血性黄疸的疗效。方法:选取本院收治的90例患儿作为研究对象,随机将其分为对照组与观察组,每组45例,对照组患儿采用口服苯巴比妥等常规药物进行治疗,观察组在口服苯巴比妥等常规治疗的基础上采用黄疸治疗箱进行间断性的蓝光照射治疗。结果:通过研究表明,观察组总有效率为91.11%,低于对照组的82.22%(P<0.05);观察组患儿不良反应的发生率为20%,低于对照组的55.56%(P<0.05);两组患儿胆红素水平变化情况比较,差异具有统计学意义(P<0.05);两组患者在进行治疗以后,血清胆红素与治疗前相比较,都存在明显的下降,粪胆素都存在明显的上升(P<0.05)。结论:对新生儿ABO溶血性黄疸患儿采用蓝光治疗照射,具有安全、可靠的特点。
Objective: To investigate the therapeutic effect of blue light therapy on neonatal ABO hemolytic jaundice. Methods: Totally 90 children admitted to our hospital were selected as study subjects and randomly divided into control group and observation group, with 45 cases in each group. Children in control group were treated with conventional drugs such as phenobarbital orally. Oral phenobarbital and other conventional treatment based on intermittent use of jaundice treatment of blue light irradiation treatment. Results: Through the study, the total effective rate in the observation group was 91.11%, which was lower than 82.22% in the control group (P <0.05). The incidence of adverse reactions in the observation group was 20%, which was lower than 55.56% in the control group <0.05). The changes of bilirubin levels in both groups were statistically significant (P <0.05). After treatment, the levels of serum bilirubin in both groups were significantly lower than those before treatment , Fecal cholestasis there is a significant increase (P <0.05). Conclusion: The neonatal ABO hemolytic jaundice treated with blue light irradiation, with safe and reliable features.